Bay Street News, May, 2020

SAN CARLOS, Calif., May 05, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions […]

Talicia® is approved by the U.S. FDA and promoted by RedHill’s U.S. sales force—Abstract discussing Talicia pharmacokinetics and exposure-response presented […]

DUBLIN, Ireland, May 05, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization […]

CHICAGO, May 05, 2020 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management […]

SOUTH SAN FRANCISCO, Calif., May 05, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]

MALVERN, Pa., May 05, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute […]

HOLLISTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for […]

REDWOOD CITY, Calif., May 05, 2020 (GLOBE NEWSWIRE) — Codexis, Inc., a leading protein engineering company and developer of novel […]

First quarter revenue of $13.9 million, a decrease of 6% compared to prior year period, due to the impact of […]

NEW HAVEN, Conn., May 05, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical […]